MEDX

MEDX
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics, aiming to capture returns from intrinsic valuation realization and scientific discovery.
About Horizon Kinetics Medical ETF
The Horizon Kinetics Medical ETF seeks long-term growth of capital by investing primarily in patented first line pharmaceuticals and biologics, aiming to capture returns from intrinsic valuation realization and scientific discovery.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
LLY | Eli Lilly and Company | 16.74% | 3.22K | $3.39M |
ABBV | AbbVie Inc. | 8.44% | 7.36K | $1.71M |
NVS | Novartis AG | 7.67% | 9.19K | $1.55M |
AZN | AstraZeneca PLC | 5.67% | 5.50K | $1.15M |
JNJ | Johnson & Johnson | 5.65% | 4.60K | $1.14M |
BMY | Bristol-Myers Squibb Company | 4.95% | 16.05K | $1.00M |
IONS | Ionis Pharmaceuticals, Inc. | 4.80% | 11.95K | $969.90K |
AMGN | Amgen Inc. | 4.34% | 2.26K | $877.24K |
MRK | Merck & Co., Inc. | 3.94% | 6.44K | $796.91K |
ALNY | Alnylam Pharmaceuticals, Inc. | 3.91% | 2.38K | $791.02K |
PFE | Pfizer Inc. | 3.39% | 24.82K | $686.38K |
ALKS | Alkermes plc | 3.29% | 22.07K | $664.19K |
GSK | GSK plc | 3.16% | 10.79K | $638.13K |
CRSP | CRISPR Therapeutics AG | 3.01% | 10.11K | $608.26K |
BIIB | Biogen Inc. | 2.83% | 2.99K | $573.16K |
REGN | Regeneron Pharmaceuticals, Inc. | 2.67% | 690 | $539.35K |
BEAM | Beam Therapeutics Inc. | 1.29% | 9.19K | $261.66K |
VNDA | Vanda Pharmaceuticals Inc. | 1.09% | 24.82K | $221.18K |
NTLA | Intellia Therapeutics, Inc. | 0.94% | 13.79K | $190.05K |
GALT | Galectin Therapeutics Inc. | 0.76% | 51.48K | $153.42K |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
Holdings (Top 20)
LLY
Eli Lilly and Company
ABBV
AbbVie Inc.
NVS
Novartis AG
AZN
AstraZeneca PLC
JNJ
Johnson & Johnson
BMY
Bristol-Myers Squibb Company
IONS
Ionis Pharmaceuticals, Inc.
AMGN
Amgen Inc.
MRK
Merck & Co., Inc.
ALNY
Alnylam Pharmaceuticals, Inc.
PFE
Pfizer Inc.
ALKS
Alkermes plc
GSK
GSK plc
CRSP
CRISPR Therapeutics AG
BIIB
Biogen Inc.
REGN
Regeneron Pharmaceuticals, Inc.
BEAM
Beam Therapeutics Inc.
VNDA
Vanda Pharmaceuticals Inc.
NTLA
Intellia Therapeutics, Inc.
GALT
Galectin Therapeutics Inc.
